MSD
The role involves leading a diagnostic development team within Companion Diagnostics, focusing on strategy development and project execution in oncology. The position requires supervision of specialized staff and collaboration with global teams to support biomarker and assay development for regulatory approval.
At MSD, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for MSD.
MSD ends takeover talks with Revolution Medicines
1 month ago
Associate Director, Companion Diagnostics
Genmab
Associate Director, Companion Diagnostics
Revolution Medicines
Scientist/Senior Scientist, Companion Diagnostics (CDx) – IHC Development
Systimmune
Associate Director, Clinical Diagnostics
Regeneron Pharmaceuticals
Biomarker Clinical Assay Lead Manager
Pfizer
Oncology Diagnostics Lead
Gilead Sciences